A Case Report on Cilostazol Induced Loss of Diabetic Control
1★, 1, 1★ Corresponding author
- 1Department of Pharmacy Practice, Al Shifa College of Pharmacy, Perinthalmanna, Kerala, INDIA.
CORRESPONDENCE
Dilip Chandrasekhar
Department of Pharmacy Practice, Al Shifa College of Pharmacy, Perinthalmanna, Kerala, INDIA.
Received: 01-06-2018; Revised: 03-07-2018; Accepted: 27-07-2018.
Volume 10, Issue 4 · pp. 489-490 · 2018 · DOI: 10.5530/jyp.2018.10.107
ABSTRACT
A 69-year-old male with known case of diabetes mellitus and hypertension was admitted with wet gangrene of right greater toe. He received cilostazol 100mg twice a day for 3 days. During this period, there was a marked elevation of blood sugar requiring higher dosage of insulin. Upon withholding the suspected drug there was a marked fall in blood glucose levels indicating a positive dechallenge. Cilostazol might have loss of diabetic control by favouring intestinal glucose absorption through increased cAMP levels and GLUT2 expression necessitating management with higher dosage of insulin.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Chandrasekhar, D., Kanjhiraparambil, N. M., & Chalappurath, D. R. (2018). A Case Report on Cilostazol Induced Loss of Diabetic Control. Journal of Young Pharmacists, 10(4), 489-490. https://doi.org/10.5530/jyp.2018.10.107
Copyright and licence
© 2018 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0